Cytokinetics Inc (USD)
CYTK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range15.22 | 15.59
52-Wk Range5.75 | 16.96
Last Close15.49
Mkt Cap (m)916.40
Dividend yield-
ISINUS23282W6057
Volume220,592
Exchange VenueNAS

Company Profile

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales28.18
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 08/11/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)47291061332-
Operating Income (m)-15-3719-113-89-
Net Income (m)-15-3816-128-106-
Basic EPS-0.41-0.970.41-2.59-1.95-
Avg. Diluted Shares Outstanding (m)3639434954-
Balance Sheet
USD201420152016201720182019
Current Assets (m)131113159274208-
Non Current Assets (m)2212214-
Total Assets (m)133115170295211-
Current Liabilities (m)2432333222-
Total Liabilities (m)------
Total Equity (m)92699411026-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-45537-102-101-
Capital Expenditure (m)-1-1-2-3-1-
Figures are quoted in USD unless stated otherwise
-0.20 (-1.29%)
$
15.29
Last Price